APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contract Pharmaceutical Manufacturing

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Selected research

Market Structure

Global Contract Pharmaceutical Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchContract Pharmaceutical Manufacturing Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Contract Pharmaceutical Manufacturing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Contract Pharmaceutical Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contract Pharmaceutical Manufacturing Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Contract Pharmaceutical Manufacturing Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.

North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.

Read the full market overview

In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.

Report Includes

This report provides an overview of the global Contract Pharmaceutical Manufacturing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contract Pharmaceutical Manufacturing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contract Pharmaceutical Manufacturing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Contract Pharmaceutical Manufacturing market size, projected growth trends, production technologies, key applications, and end-use industries.

Contract Pharmaceutical Manufacturing Segment by Company

Catalent

DPx

Lonza

Piramal Healthcare

Aenova

Jubilant

Famar

Boehringer Ingelheim

Fareva Holding

AbbVie

Nipro Corp

Vetter

Sopharma

DPT Laboratories

Recipharm

NextPharma

Dishman

Aesica

Contract Pharmaceutical Manufacturing Segment by Type

Oral

Injectable

API

Other

Contract Pharmaceutical Manufacturing Segment by Application

Large Enterprise

Small Medium Enterprise

Contract Pharmaceutical Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contract Pharmaceutical Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contract Pharmaceutical Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contract Pharmaceutical Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Contract Pharmaceutical Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Contract Pharmaceutical Manufacturing industry.

Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Pharmaceutical Manufacturingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Table 3. Key Players of Injectable Table 4. Key Players of API Table 3. Key Players of Other Table 4. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Large Enterprise Table 6. Key Players of Small Medium Enterprise Table 7. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Contract Pharmaceutical Manufacturing Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Contract Pharmaceutical Manufacturing Market Share by Region (2021-2026) Table 10. Global Contract Pharmaceutical Manufacturing Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Contract Pharmaceutical Manufacturing Market Share by Region (2027-2032) Table 12. Contract Pharmaceutical Manufacturing Industry Trends Table 13. Contract Pharmaceutical Manufacturing Industry Drivers Table 14. Contract Pharmaceutical Manufacturing Industry Opportunities and Challenges Table 15. Contract Pharmaceutical Manufacturing Industry Restraints Table 16. Global Contract Pharmaceutical Manufacturing Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Company (2021-2026) Table 18. Global Contract Pharmaceutical Manufacturing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Contract Pharmaceutical Manufacturing Key Company Head Office and Area Served Table 20. Global Contract Pharmaceutical Manufacturing Company, Product Type & Application Table 21. Global Contract Pharmaceutical Manufacturing Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Contract Pharmaceutical Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Contract Pharmaceutical Manufacturing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2021-2026) Table 28. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2027-2032) Table 29. Global Contract Pharmaceutical Manufacturing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2021-2026) Table 33. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2027-2032) Table 34. Catalent Company Information Table 35. Catalent Business Overview Table 36. Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Catalent Contract Pharmaceutical Manufacturing Product Portfolio Table 38. Catalent Recent Development Table 39. DPx Company Information Table 40. DPx Business Overview Table 41. DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. DPx Contract Pharmaceutical Manufacturing Product Portfolio Table 43. DPx Recent Development Table 44. Lonza Company Information Table 45. Lonza Business Overview Table 46. Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Lonza Contract Pharmaceutical Manufacturing Product Portfolio Table 48. Lonza Recent Development Table 49. Piramal Healthcare Company Information Table 50. Piramal Healthcare Business Overview Table 51. Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio Table 53. Piramal Healthcare Recent Development Table 54. Aenova Company Information Table 55. Aenova Business Overview Table 56. Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Aenova Contract Pharmaceutical Manufacturing Product Portfolio Table 58. Aenova Recent Development Table 59. Jubilant Company Information Table 60. Jubilant Business Overview Table 61. Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Jubilant Contract Pharmaceutical Manufacturing Product Portfolio Table 63. Jubilant Recent Development Table 64. Famar Company Information Table 65. Famar Business Overview Table 66. Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Famar Contract Pharmaceutical Manufacturing Product Portfolio Table 68. Famar Recent Development Table 69. Boehringer Ingelheim Company Information Table 70. Boehringer Ingelheim Business Overview Table 71. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio Table 73. Boehringer Ingelheim Recent Development Table 74. Fareva Holding Company Information Table 75. Fareva Holding Business Overview Table 76. Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio Table 78. Fareva Holding Recent Development Table 79. AbbVie Company Information Table 80. AbbVie Business Overview Table 81. AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. AbbVie Contract Pharmaceutical Manufacturing Product Portfolio Table 83. AbbVie Recent Development Table 84. Nipro Corp Company Information Table 85. Nipro Corp Business Overview Table 86. Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio Table 88. Nipro Corp Recent Development Table 89. Vetter Company Information Table 90. Vetter Business Overview Table 91. Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Vetter Contract Pharmaceutical Manufacturing Product Portfolio Table 93. Vetter Recent Development Table 94. Sopharma Company Information Table 95. Sopharma Business Overview Table 96. Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Sopharma Contract Pharmaceutical Manufacturing Product Portfolio Table 98. Sopharma Recent Development Table 99. DPT Laboratories Company Information Table 100. DPT Laboratories Business Overview Table 101. DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio Table 103. DPT Laboratories Recent Development Table 104. Recipharm Company Information Table 105. Recipharm Business Overview Table 106. Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Recipharm Contract Pharmaceutical Manufacturing Product Portfolio Table 108. Recipharm Recent Development Table 109. NextPharma Company Information Table 110. NextPharma Business Overview Table 111. NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. NextPharma Contract Pharmaceutical Manufacturing Product Portfolio Table 113. NextPharma Recent Development Table 114. Dishman Company Information Table 115. Dishman Business Overview Table 116. Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Dishman Contract Pharmaceutical Manufacturing Product Portfolio Table 118. Dishman Recent Development Table 119. Aesica Company Information Table 120. Aesica Business Overview Table 121. Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Aesica Contract Pharmaceutical Manufacturing Product Portfolio Table 123. Aesica Recent Development Table 124. North America Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026) & (US$ Million) Table 125. North America Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032) & (US$ Million) Table 126. North America Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026) & (US$ Million) Table 127. North America Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032) & (US$ Million) Table 128. North America Contract Pharmaceutical Manufacturing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026) Table 130. North America Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032) Table 131. Europe Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026) & (US$ Million) Table 132. Europe Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032) & (US$ Million) Table 133. Europe Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026) & (US$ Million) Table 134. Europe Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032) & (US$ Million) Table 135. Europe Contract Pharmaceutical Manufacturing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026) Table 137. Europe Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032) Table 138. China Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026) & (US$ Million) Table 139. China Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032) & (US$ Million) Table 140. China Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026) & (US$ Million) Table 141. China Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032) & (US$ Million) Table 142. Asia Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026) & (US$ Million) Table 143. Asia Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032) & (US$ Million) Table 144. Asia Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026) & (US$ Million) Table 145. Asia Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032) & (US$ Million) Table 146. Asia Contract Pharmaceutical Manufacturing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026) Table 148. Asia Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032) Table 149. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026) & (US$ Million) Table 150. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032) & (US$ Million) Table 151. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026) Table 155. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Contract Pharmaceutical Manufacturing Product Image Figure 2. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Contract Pharmaceutical Manufacturing Market Share by Type: 2025 VS 2032 Figure 4. Oral Image Figure 5. Injectable Image Figure 6. API Image Figure 7. Other Image Figure 8. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Contract Pharmaceutical Manufacturing Market Share by Application: 2025 VS 2032 Figure 10. Large Enterprise Image Figure 11. Small Medium Enterprise Image Figure 12. Global Contract Pharmaceutical Manufacturing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 14. Global Contract Pharmaceutical Manufacturing Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Contract Pharmaceutical Manufacturing Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Contract Pharmaceutical Manufacturing Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Contract Pharmaceutical Manufacturing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2021-2032) Figure 21. Global Contract Pharmaceutical Manufacturing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2021-2032) Figure 23. North America Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 24. North America Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032) Figure 25. North America Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032) Figure 26. North America Contract Pharmaceutical Manufacturing Market Share by Country (2021-2032) Figure 27. United States Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 28. Canada Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 30. Europe Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 31. Europe Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032) Figure 32. Europe Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032) Figure 33. Europe Contract Pharmaceutical Manufacturing Market Share by Country (2021-2032) Figure 34. Germany Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 35. France Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 37. Italy Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 38. Russia Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 40. China Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 41. China Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032) Figure 42. China Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032) Figure 43. Asia Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 44. Asia Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032) Figure 45. Asia Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032) Figure 46. Asia Contract Pharmaceutical Manufacturing Market Share by Country (2021-2032) Figure 47. Japan Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 51. India Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 52. Australia Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Share by Country (2021-2032) Figure 57. Brazil Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 62. UAE Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 64. Chile Contract Pharmaceutical Manufacturing Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injectable
  • API
  • Other
Applications
  • Large Enterprise
  • Small Medium Enterprise
Companies covered
  • Catalent
  • DPx
  • Lonza
  • Piramal Healthcare
  • Aenova
  • Jubilant
  • Famar
  • Boehringer Ingelheim
  • Fareva Holding
  • AbbVie
  • Nipro Corp
  • Vetter
  • Sopharma
  • DPT Laboratories
  • Recipharm
  • NextPharma
  • Dishman
  • Aesica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injectable
  6. 1.2.4 API
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Large Enterprise
  11. 1.3.3 Small Medium Enterprise
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Contract Pharmaceutical Manufacturing Growth Trends by Region
  14. 1.5.1 Global Contract Pharmaceutical Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Contract Pharmaceutical Manufacturing Market Size by Region (2021-2026)
  16. 1.5.3 Contract Pharmaceutical Manufacturing Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Contract Pharmaceutical Manufacturing Market Dynamics
  1. 2.1 Contract Pharmaceutical Manufacturing Industry Trends
  2. 2.2 Contract Pharmaceutical Manufacturing Industry Drivers
  3. 2.3 Contract Pharmaceutical Manufacturing Industry Opportunities and Challenges
  4. 2.4 Contract Pharmaceutical Manufacturing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Contract Pharmaceutical Manufacturing Revenue by Company (2021-2026)
  2. 3.2 Global Contract Pharmaceutical Manufacturing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Contract Pharmaceutical Manufacturing Key Company Head office and Area Served
  4. 3.4 Global Contract Pharmaceutical Manufacturing Company, Product Type & Application
  5. 3.5 Global Contract Pharmaceutical Manufacturing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Contract Pharmaceutical Manufacturing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Contract Pharmaceutical Manufacturing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Contract Pharmaceutical Manufacturing Tier 1, Tier 2, and Tier 3
4 Contract Pharmaceutical Manufacturing Market by Type
  1. 4.1 Global Contract Pharmaceutical Manufacturing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Contract Pharmaceutical Manufacturing Market Size by Type (2021-2032)
  3. 4.3 Global Contract Pharmaceutical Manufacturing Market Size Share by Type (2021-2032)
5 Contract Pharmaceutical Manufacturing Market by Application
  1. 5.1 Global Contract Pharmaceutical Manufacturing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Contract Pharmaceutical Manufacturing Market Size by Application (2021-2032)
  3. 5.3 Global Contract Pharmaceutical Manufacturing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Catalent
  2. 6.1.1 Catalent Company Information
  3. 6.1.2 Catalent Business Overview
  4. 6.1.3 Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Catalent Contract Pharmaceutical Manufacturing Product Portfolio
  6. 6.1.5 Catalent Recent Developments
  7. 6.2 DPx
  8. 6.2.1 DPx Company Information
  9. 6.2.2 DPx Business Overview
  10. 6.2.3 DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 DPx Contract Pharmaceutical Manufacturing Product Portfolio
  12. 6.2.5 DPx Recent Developments
  13. 6.3 Lonza
  14. 6.3.1 Lonza Company Information
  15. 6.3.2 Lonza Business Overview
  16. 6.3.3 Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Lonza Contract Pharmaceutical Manufacturing Product Portfolio
  18. 6.3.5 Lonza Recent Developments
  19. 6.4 Piramal Healthcare
  20. 6.4.1 Piramal Healthcare Company Information
  21. 6.4.2 Piramal Healthcare Business Overview
  22. 6.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio
  24. 6.4.5 Piramal Healthcare Recent Developments
  25. 6.5 Aenova
  26. 6.5.1 Aenova Company Information
  27. 6.5.2 Aenova Business Overview
  28. 6.5.3 Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Aenova Contract Pharmaceutical Manufacturing Product Portfolio
  30. 6.5.5 Aenova Recent Developments
  31. 6.6 Jubilant
  32. 6.6.1 Jubilant Company Information
  33. 6.6.2 Jubilant Business Overview
  34. 6.6.3 Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Jubilant Contract Pharmaceutical Manufacturing Product Portfolio
  36. 6.6.5 Jubilant Recent Developments
  37. 6.7 Famar
  38. 6.7.1 Famar Company Information
  39. 6.7.2 Famar Business Overview
  40. 6.7.3 Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Famar Contract Pharmaceutical Manufacturing Product Portfolio
  42. 6.7.5 Famar Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
  49. 6.9 Fareva Holding
  50. 6.9.1 Fareva Holding Company Information
  51. 6.9.2 Fareva Holding Business Overview
  52. 6.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio
  54. 6.9.5 Fareva Holding Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AbbVie Contract Pharmaceutical Manufacturing Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 Nipro Corp
  62. 6.11.1 Nipro Corp Company Information
  63. 6.11.2 Nipro Corp Business Overview
  64. 6.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio
  66. 6.11.5 Nipro Corp Recent Developments
  67. 6.12 Vetter
  68. 6.12.1 Vetter Company Information
  69. 6.12.2 Vetter Business Overview
  70. 6.12.3 Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Vetter Contract Pharmaceutical Manufacturing Product Portfolio
  72. 6.12.5 Vetter Recent Developments
  73. 6.13 Sopharma
  74. 6.13.1 Sopharma Company Information
  75. 6.13.2 Sopharma Business Overview
  76. 6.13.3 Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Sopharma Contract Pharmaceutical Manufacturing Product Portfolio
  78. 6.13.5 Sopharma Recent Developments
  79. 6.14 DPT Laboratories
  80. 6.14.1 DPT Laboratories Company Information
  81. 6.14.2 DPT Laboratories Business Overview
  82. 6.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio
  84. 6.14.5 DPT Laboratories Recent Developments
  85. 6.15 Recipharm
  86. 6.15.1 Recipharm Company Information
  87. 6.15.2 Recipharm Business Overview
  88. 6.15.3 Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Recipharm Contract Pharmaceutical Manufacturing Product Portfolio
  90. 6.15.5 Recipharm Recent Developments
  91. 6.16 NextPharma
  92. 6.16.1 NextPharma Company Information
  93. 6.16.2 NextPharma Business Overview
  94. 6.16.3 NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 NextPharma Contract Pharmaceutical Manufacturing Product Portfolio
  96. 6.16.5 NextPharma Recent Developments
  97. 6.17 Dishman
  98. 6.17.1 Dishman Company Information
  99. 6.17.2 Dishman Business Overview
  100. 6.17.3 Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Dishman Contract Pharmaceutical Manufacturing Product Portfolio
  102. 6.17.5 Dishman Recent Developments
  103. 6.18 Aesica
  104. 6.18.1 Aesica Company Information
  105. 6.18.2 Aesica Business Overview
  106. 6.18.3 Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Aesica Contract Pharmaceutical Manufacturing Product Portfolio
  108. 6.18.5 Aesica Recent Developments
7 North America
  1. 7.1 North America Contract Pharmaceutical Manufacturing Market Size (2021-2032)
  2. 7.2 North America Contract Pharmaceutical Manufacturing Market Size by Type
  3. 7.2.1 North America Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026)
  4. 7.2.2 North America Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032)
  5. 7.2.3 North America Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032)
  6. 7.3 North America Contract Pharmaceutical Manufacturing Market Size by Application
  7. 7.3.1 North America Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026)
  8. 7.3.2 North America Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032)
  9. 7.3.3 North America Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032)
  10. 7.4 North America Contract Pharmaceutical Manufacturing Market Size by Country
  11. 7.4.1 North America Contract Pharmaceutical Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
  13. 7.4.3 North America Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
  14. 7.4.4 North America Contract Pharmaceutical Manufacturing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Contract Pharmaceutical Manufacturing Market Size (2021-2032)
  2. 8.2 Europe Contract Pharmaceutical Manufacturing Market Size by Type
  3. 8.2.1 Europe Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032)
  6. 8.3 Europe Contract Pharmaceutical Manufacturing Market Size by Application
  7. 8.3.1 Europe Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032)
  10. 8.4 Europe Contract Pharmaceutical Manufacturing Market Size by Country
  11. 8.4.1 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Contract Pharmaceutical Manufacturing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Contract Pharmaceutical Manufacturing Market Size (2021-2032)
  2. 9.2 China Contract Pharmaceutical Manufacturing Market Size by Type
  3. 9.2.1 China Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026)
  4. 9.2.2 China Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032)
  5. 9.2.3 China Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032)
  6. 9.3 China Contract Pharmaceutical Manufacturing Market Size by Application
  7. 9.3.1 China Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026)
  8. 9.3.2 China Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032)
  9. 9.3.3 China Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Contract Pharmaceutical Manufacturing Market Size (2021-2032)
  2. 10.2 Asia Contract Pharmaceutical Manufacturing Market Size by Type
  3. 10.2.1 Asia Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032)
  6. 10.3 Asia Contract Pharmaceutical Manufacturing Market Size by Application
  7. 10.3.1 Asia Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032)
  10. 10.4 Asia Contract Pharmaceutical Manufacturing Market Size by Country
  11. 10.4.1 Asia Contract Pharmaceutical Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Contract Pharmaceutical Manufacturing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Contract Pharmaceutical Manufacturing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst